Amneal Pharmaceuticals, Inc. (AMRX) Financial Analysis & Valuation | Quarter Chart
Amneal Pharmaceuticals, Inc. (AMRX)
AMRXPrice: $17.29
Fair Value: 🔒
🔒score
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Gen... more
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, mark... more
Description
Shares
| Market Cap | $5.52B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | US | CEO | Chirag K. Patel |
| IPO Date | 2018-05-07 | CAGR | 0.13% |
| Employees | 8,300 | Website | www.amneal.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
AMRX chart loading...
Fundamentals
Technicals
| Enterprise Value | $8.02B | P/E Ratio | 19.21 |
| Forward P/E | 15.39 | PEG Ratio | 0.12 |
| P/S Ratio | 2.45 | P/B Ratio | -169.29 |
| P/CF Ratio | 25.31 | P/FCF Ratio | 36.32 |
| EPS | $0.9 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 7.62% | Gross Margin | 0.39% |
| Operating Margin | 0.12% | Profit Margin | 0.04% |
| ROE | -1.45% | ROA | 0.03% |
| ROCE | 0.13% | Current Ratio | 2.47 |
| Quick Ratio | 1.59 | Cash Ratio | 0.27 |
| Debt/Equity | -59.38 | Interest Coverage | 1.51 |
| Altman Z Score | 2.33 | Piotroski Score | 7 |